Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALBPS stock hub

EPA/ALBPS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALBPSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALBPSEPA/ALBPS

—

Loading chart…

In the news

Latest news · EPA/ALBPS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-319.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALBPS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

EUR

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	19
Employees Change	-3%
Employees Change Percent	-13.64
Enterprise value	EUR 8.4M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0012816825
Last refreshed	2026-05-10
Market cap	EUR 1.9M
Price	EUR 0.02
Price currency	EUR
Sector	Healthcare
Sic	2836
Symbol	epa/ALBPS
Website	https://www.biophytis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-417.35%
EV Earnings	-1.05x
EV/FCF	-1.32x
FCF yield	-331.33%
P/B ratio	-0.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -8M
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Profit Per Employee	EUR -422,632
ROA	-66.56
Roa5y	-50.62
ROCE	187.3
ROIC	-319.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-68.08%
Cagr1y	-86.73%
Cagr3y	-87.96%
Cagr5y	-86.25%
EPS Growth Quarters	13
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 6.6M
Cash	EUR 1.2M
Current Assets	EUR 3.8M
Current Liabilities	EUR 11M
Debt	EUR 7.7M
Debt FCF	EUR -1.21
Equity	EUR -7.8M
Interest Coverage	-11.3
Liabilities	EUR 14.4M
Long Term Assets	EUR 2.8M
Long Term Liabilities	EUR 3.5M
Net Cash	EUR -6.5M
Net Cash By Market Cap	EUR -338
Tangible Book Value	EUR -10.4M
Tangible Book Value Per Share	EUR -0.44
WACC	7.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.35
Net Working Capital	EUR -3.8M
Quick ratio	0.33
Working Capital	EUR -7.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-384.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-86.71%
200-day SMA	0.09
3Y total return	-99.83%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	7,720
All Time High Change	-100%
All Time High Date	2015-08-05
All Time Low	0.02
All Time Low Change	37.25%
All Time Low Date	2026-04-07
ATR	0
Beta	0.86
Beta1y	0.15
Beta2y	0.53
Ch YTD	-68.23
High	0.02
High52	0.22
High52 Date	2025-07-31
High52ch	-90.37%
Low	0.02
Low52	0.02
Low52 Date	2026-04-07
Low52ch	37.26%
Ma50ch	-23.08%
Price vs 200-day SMA	-77.25%
RSI	47.19
RSI Monthly	29.19
RSI Weekly	18.99
Sharpe ratio	-1.76x
Sortino ratio	-2.58
Total Return	-384.68%
Tr YTD	-68.23
Tr1m	31.25%
Tr1w	17.98%
Tr3m	-63.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -8.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	1,846,000
Shares Institutions	2.08%
Shares Out	91,622,088
Shares Qo Q	179.95%
Shares Yo Y	384.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -6.6M
Average Volume	7,324,349.25x
Bv Per Share	-0.33
CAPEX	EUR 9,000
Ch10y	-100
Ch1m	31.25
Ch1w	17.98
Ch1y	-86.71
Ch3m	-63.86
Ch3y	-99.83
Ch5y	-100
Ch6m	-79.41
Change	0.48%
Change From Open	0
Close	0.02
Days Gap	0.48
Depreciation Amortization	302,000
Dollar Volume	116,923.4
Earnings Date	2026-05-21
EBIT	EUR -8.2M
EBITDA	EUR -7.9M
EPS	EUR -0.61
F Score	2
FCF	EUR -6.4M
FCF EV Yield	-75.9x
FCF Per Share	EUR -0.07
Financing CF	5,383,000
Fiscal Year End	December
Founded	2,006
Investing CF	19,000
Is Primary Listing	1
Last Earnings Date	2025-09-26
Last Report Date	2025-06-30
Last Split Date	2024-05-03
Last Split Type	Reverse
Ma150	0.07
Ma150ch	-68.18%
Ma20	0.02
Ma20ch	7.69%
Net CF	-985,000
Next Earnings Date	2026-05-21
Open	0.02
Position In Range	13.33
Ppne	182,000
Price Date	2026-05-08
Relative Volume	0.79x
Share Based Comp	261,000
Tr6m	-79.41%
Volume	5,567,780

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALBPS pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALBPS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/ALBPS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+384.7%

Negative means the company is buying back shares.

Technical

EPA/ALBPS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.2

Neutral momentum band

Price vs 200-day MA

-77.2%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

-1.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALBPS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALBPS stock rating?

epa/ALBPS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALBPS analysis?

The full report lives at /stocks/epa/ALBPS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALBPS?

The latest report frames epa/ALBPS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALBPS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.